Molson Coors announces partnership with Fever-Tree in US
Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its premiumisation and ‘Beyond Beer’ strategies. Through the deal, Molson Coors will assume exclusive commercialisation rights to Fever-Tree’s range of tonics, ginger beers, cocktail mixers and more in the US, starting from 1 February 2025.
In a report released today, Lauren Lieberman from Barclays maintained a Sell rating on Molson Coors (TAP – Research Report), with a price ...
Of the three alcoholic beverage stocks, I personally see the most value in Molson Coors, which at a price-to-earnings ratio of less than 13 and paying a 3% dividend, might actually end up being ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback